Ovarian cancer is a type of cancer that starts in the ovaries. It most often occurs in women over 50. Ovarian cancer may cause no symptoms at all, or cause symptoms, such as bloating, abdominal pain, and trouble eating, that can be mistaken for other conditions. Although it’s difficult to catch ovarian cancer earlyabout 20% of ovarian cancers are detected before they spread outside the ovarythere are treatments that can help.
Ovarian Cancer News
By Amy NortonHealthDay Reporter SATURDAY, March 28, 2015 (HealthDay News) — An experimental vaccine and a drug already on the market each may help slow down advanced ovarian cancer, two new studies suggest. In one, of just 31 patients, researchers found that adding the vaccine to standard treatment staved off a recurrence in women who had advanced-stage [...]
By Dennis ThompsonHealthDay Reporter TUESDAY, March 24, 2015 (HealthDay News) — Angelina Jolie’s decision to talk about the removal of her ovaries has brought new public attention to what is actually standard preventive care for women whose genetics dramatically increase their risk of ovarian cancer, experts say. In a column published Tuesday in the New York [...]
By Steven ReinbergHealthDay Reporter THURSDAY, Feb. 19, 2015 (HealthDay News) — Survival rates are improving for many people with cancers of the breast, prostate, lung, liver and colon or rectum, especially for those diagnosed at younger ages, a new study reports. Cancer is still a leading cause of death in the United States, but advances in radiation, [...]
By Kathleen DohenyHealthDay Reporter THURSDAY, Feb. 12, 2015 (HealthDay News) — Women who use hormone therapy after menopause — even for just a few years — may have an increased risk of ovarian cancer, according to new research. The new study found that when women used hormone replacement therapy for less than five years after menopause, the [...]
FRIDAY, Dec. 19, 2014 (HealthDay News) — The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to identify patients eligible to receive the drug. Lynparza (olaparib) belongs to a new class of drugs called poly ADP-ribose polymerase (PARP) inhibitors. The drug is for women who [...]